Rationale and Design of a Randomized, Double-Blind, Event-Driven, Multicentre Study Comparing the Efficacy and Safety of Oral Rivaroxaban with Placebo for Reducing the Risk of Death, Myocardial Infarction or Stroke in Subjects with Heart Failure and Significant Coronary Artery Disease Following an Exacerbation of Heart Failure: The COMMANDER HF TrialFaı̈ez Zannad, Roger M. Mills, Dirk J. Van Veldhuisen et al.|European Journal of Heart Failure|2015Cited by 78
Global research trends in Chinese medicine for the treatment of non-alcoholic fatty liver disease (NAFLD): A bibliometric studyKangjie Li, Chongbo Zhao, Jie Wang et al.|Pharmacological Research - Modern Chinese Medicine|2025Cited by 2